Faculty Opinions recommendation of Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (canagliflozin cardiovascular assessment study).
2021 ◽
Vol 41
(3)
◽
pp. 137-140
2019 ◽
Vol 15
(1)
◽
pp. 135-143
◽
2005 ◽
Vol 155
(17-18)
◽
pp. 397-403
2016 ◽
Vol 41
(3)
◽
pp. 493-504
◽